Hi,
moomoo ID:NaN
Log Out
English
Back
Log in to access Online Inquiry
Multi-dimentional Analyses
Company Valuation Capital Tracking Short Selling Data
Moomoo > Quotes > 02235 MICROTECH MED-B > Detailed Quotes

02235 MICROTECH MED-B

Watchlist
8.650
-0.380-4.21%
Closed  02/03 16:08 CCT
High
8.900
Open
8.900
Turnover
5.67M
Low
7.930
Pre Close
9.030
Volume
629.80K
Market Cap
3.68B
P/E(TTM)
Loss
52wk High
18.100
Shares
425.74M
P/E(Static)
Loss
52wk Low
5.640
Float Cap
1.47B
Bid/Ask %
35.14%
Historical High
31.700
Shs Float
170.32M
Volume Ratio
5.32
Historical Low
5.640
Dividend TTM
--
Div Yield TTM
--
P/B
1.41
Dividend LFY
--
Div Yield LFY
--
Turnover Ratio
0.37%
Amplitude
10.74%
Avg Price
8.996
Lot Size
100
Float Cap
1.47B
Bid/Ask %
35.14%
Historical High
31.700
Shs Float
170.32M
Volume Ratio
5.32
Historical Low
5.640
Dividend TTM
--
P/B
1.41
Dividend LFY
--
Turnover Ratio
0.37%
Amplitude
10.74%
Avg Price
8.996
Lot Size
100
Price Forecast

News

Comment

Company Overview More
Weitai Medical Devices (Hangzhou) Co., Ltd. is a pioneer in the field of medical devices for diabetes management. Through innovation and integration of diabetes treatment and monitoring technology, Weitai Medical Devices (Hangzhou) Co., Ltd. has been able to reshape a new model of diabetes management in China and around the world. The company was founded in 2011 and is headquartered in Zhejiang Overseas High-Level Talent Innovation Park - Hangzhou Future Science and Technology City. It has been designated as a key enterprise research center for diabetes treatment devices in Zhejiang Province, China, and has also established a R&D center in Silicon Valley. Weitai Healthcare has a strong in-house R&D team of nearly 100 members, including academics, scientists, elite engineers and experienced experts from world-renowned universities. More than 30% of R&D members have master's or doctorate degrees. Our main R&D personnel have an average of 13 years of relevant R&D experience, of which more than a dozen have worked for top medical device companies. Weitai Medical focuses on technological innovation in the field of medical devices for diabetes management, and is committed to promoting the company's products to the global market. Currently, the company's main products include: Treatment products Equil submersible insulin pump system Diagnostic products AIDEX Dynamic Blood Glucose Monitoring System (CGMS) Various blood sugar monitoring systems (BGMS) As we all know about POCT products, diabetics face many problems in their lives, and a series of products produced by Weitai Medical have brought them a free and flexible experience, and also given them more choices in their lives.
CEO: Pan Zheng
Market: Hong Kong motherboard
Listing Date: 10/19/2021
Paper Trade More
Direction
Buy
Sell
Types
LMT Order
Price
QTY
Amount
--
Hot List
TradeSearchNews
SymbolLatest price%Chg

Loading...

Watchlist